Publications

Comparison of liquid versus solid tissue genomic profiling for the prediction of chemo-immunotherapy benefit in advanced NSCLC

AACR,

Computational modeling of comprehensive genomic profiling to predict chemo-immunotherapy benefit in early stage NSCLC

AACR,

An evidence-based tool to systematically identify potential adverse drug-drug interactions.

AACR,

Use of biosimulation to predict immune checkpoint inhibitor resistance in patients with high microsatellite instability

AACR,

Cellworks Therapy Response Index Coupled with Personalized Tumor Microenvironment Modeling Predicts Overall Survival for Immunotherapy Treatment in NSCLC Patients

SITC,

Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach

ACOP,

Use of Biosimulation to Predict Chemotherapy Benefit in Patients with Metastatic NSCLC Being Treated with Immunotherapy

WCLC,

Use of Biosimulation to Predict Concomitant Chemotherapy Benefit in NSCLC Patients with EGFR Mutations Being Treated with Osimertinib

WCLC,

STAY INFORMED

Top